Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 70518-4260

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 70518-4260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is the description: "Lurasidone HCI 20 mg Tablet, a prescription medication manufactured by Ascend Labs, LLC. Each bottle contains 30 tablets of the product. Keep out of reach of children. Store at 20-25°C (58-77°F); excursions permitted to 15-30°C (59-86°F) as per USP guidelines."*

FDA Label Image

Lurasidone-structure (Lurasidone 1)

FDA Label Image

Lurasidone-fig2 (Lurasidone Fig2)

This text discusses the impact of other drugs on the pharmacokinetics of Lurasidone. It mentions the fold change and 90% CI values for the interacting drugs Ketoconazole and Ritonavir. Additionally, it includes information on the CYP1A2 inhibitor and inducer drugs. The text also indicates changes relative to Lurasidone when these drugs are used.*

FDA Label Image

Lurasidone-fig2 (Lurasidone Fig3)

This text appears to be a report on drug interactions involving different substances and their effects. It includes information about dosages ("035 mg"), interactions between medications ("Fold Change"), and statistical analysis ("90% CI"). The text seems to provide insights into the impact of combining drugs on specific substrates.*

FDA Label Image

Lurasidone-fig3 (Lurasidone Fig4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.